Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomic analysis of HT-1080 cells overexpressing protein ARGLU1

ABSTRACT: A proteomic comparison between normal HT-1080 cells and HT-1080 cells that have been stably transfected to overexpress protein arginie and glutamate rich 1 (ARGLU1).

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Permanent Cell Line Cell, Cell Culture

DISEASE(S): Fibrosarcoma

SUBMITTER: Drayson Graves

LAB HEAD: Peter Pelka

PROVIDER: PXD046329 | Pride | 2024-05-13

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	S13075_1_H_1_220408.mzid.gz	Mzid
	S13075_1_H_1_220408.mzid_S13075_1_H_1_220408.MGF	Mzid
	S13075_1_H_1_220408.raw	Raw
	S13076_2_H_2_220408.mzid.gz	Mzid
	S13076_2_H_2_220408.mzid_S13076_2_H_2_220408.MGF	Mzid

Items per page:

1 - 5 of 19

Similar Datasets

Proteomic analysis of Human Adenovirus B and C infections in the presence of interferon

Project description:Human adenoviruses (HAdV) are a large family of DNA viruses generally infecting the airway, the gut, the eye, and the urinary tract. However, certain strains of HAdVs are capable of causing severe infections in the very young, the elderly, the immunocompromised, and sometimes healthy individuals. In particular, species B HAdVs are often associated with more severe disease, involving serotype 7 and 14. Despite the severity of the disease caused by these strains, little is known about the molecular mechanisms underpinning the disease outcomes. Activation of interferon stimulated genes (ISGs) occurs rapidly after interferon (IFN) stimulation and relies on recruitment of the transcription factor complex IFN-stimulated gene factor 3 (ISGF3) to promoters, which happens via the canonical JAK-STAT pathway. Therefore, suppression of IFNs is a key aspect of evading innate immunity by viral pathogens, including HAdVs; and as such, HAdVs have evolved multiple ways by which they suppress activation of ISGs in order to drive viral replication. Our previous work investigated the molecular mechanism of interferon suppression by HAdV-C5. We observed that E1A of HAdV-C5 interacts with the AAA+ DNA helicase RuvBL1/Pontin in order to suppress activation of interferon stimulated genes (ISGs) during infection. We therefore wanted to determine whether RuvBL1 is also a target for the more highly pathogenic HAdV-B7 and B14. As part of this investigation, we examined the broad-range effect of HAdV species C2, B7, and B14 on cells in response to interferon. These results are presented here.

2024-06-26 | PXD045673 | Pride

Affinity Purification of Arglu1 and Human Adenovirus B7 E1A-Associated Proteins

Project description:Identification of novel cellular binding partners of human Arglu1 and human adenovirus B7 E1A.

2024-05-13 | PXD050223 | Pride

RepliSeq of HT-1080 cell line

2014-07-31 | GSE58907 | GEO

Mitochondria help avoid glucose addiction in cancer cells

Project description:Cancer cells consume large amounts of glucose because of their specific metabolic pathway. However, cancer cells exist in tumor tissue where glucose is insufficient. To survive, cancer cells likely have the mechanism to elude their glucose addiction. Here we show that functional mitochondria are essential if cancer cells are to avoid glucose addiction. Cancer cells with dysfunctional mitochondria, such as mitochondrial DNA-deficient rho0 cells and electron transport chain blocker-treated cells, were highly sensitive to glucose deprivation. Our data demonstrated that this sensitization was caused by failure of the unfolded protein response (UPR), an adaptive response mediated by the endoplasmic reticulum (ER). This study suggests a link between mitochondria and the ER during the UPR under glucose deprivation conditions and that mitochondria govern cell fate, not only through ATP production and apoptosis regulation but also through modulating the UPR for cell survival. Human cancer cell lines (HT-1080, HT-29, and mtDNA-deficient cells derived from these cell lines) were selected for RNA extraction and hybridization on Affymetrix microarrays. We examined the unfolded protein response (UPR), an adaptive response mediated by the endoplasmic reticulum (ER), of cancer cells under stress conditions. Abbreviations List: AA, antimycin A; Bu, buformin; Met, metformin; Phen, phenformin; Rot, rotenone; VST, versipelostatin; TM, tunicamycin; 2DG, 2-deoxyglucose; GS, glucose starvation. Capital S (_S) indicates the supernatant of sample including floating cells.

2010-05-28 | E-GEOD-16157 | biostudies-arrayexpress

RepliSeq of HT-1080 cell line

Project description:Analysis of replication timing by RepliSeq of HT-1080 Human Connective Tissue Fibrosarcoma Cells. HT-1080 subclone +4 cell line as described in “Human gene targeting favors insertions over deletions.” Russell, D.W., and Hirata, R.K. (2008). Hum Gene Ther 19, 907-914. RepliSeq of HT-1080 cell line was used to determine the impact of DNA replication on targeted adeno-associated virus sites by mapping replication forks, which revealed a consistent preference for recombination at target loci transcribed towards an incoming fork.

2014-07-31 | E-GEOD-58907 | biostudies-arrayexpress

Development of gene expression signatures for subconfluent and overconfluent HT-1080 fibrosarcoma cell line

Project description:We investigated the changes in gene expression profile between subconfluent (80%) and overconfluent HT-1080 fibrosarcoma cell line. We have employed whole genome microarray expression profiling as a discovery platform to identify genes expression profiles in HT-1080 cells. Total RNAs from subconfluent (HT-1080_80%) and overconfluent (HT-1080_overconfluent) HT-1080 cells were harvested and subjected to the microarray analysis.

2015-06-04 | E-GEOD-69534 | biostudies-arrayexpress

Development of gene expression signatures for subconfluent and overconfluent HT-1080 fibrosarcoma cell line

Project description:We investigated the changes in gene expression profile between subconfluent (80%) and overconfluent HT-1080 fibrosarcoma cell line.

2015-06-04 | GSE69534 | GEO

Genes regulated in HT-1080 cells after 24 hours of treatment with IRAK4 inhibitor

Project description:Analysis of HT-1080 fibrosarcoma cells transcriptome following 24 hours treatment with IRAK4 inhibitor was performed. Results provide insight into mode of action of IRAK4 inhibitor under study. Project co-financed from European Regional Development Fund under The Operational Program Innovative Economy, 2007-2013, measure 1.4 (UDA-POIG.01.04.00-12-049/11-00)

2018-11-24 | GSE122845 | GEO

Genes regulated in HT-1080 cells after 4 hours of treatment with IRAK4 inhibitor

Project description:Analysis of HT-1080 fibrosarcoma cells transcriptome following 4 hours treatment with IRAK4 inhibitor was performed. Results provide insight into mode of action of IRAK4 inhibitor under study. Project co-financed from European Regional Development Fund under The Operational Program Innovative Economy, 2007-2013, measure 1.4 (UDA-POIG.01.04.00-12-049/11-00)

2018-11-24 | GSE122844 | GEO

Aqueous and DMSO extracts from Annona muricata leaves protect from ferroptosis to both HT-1080 fibrosarcoma cells and HMEC-1 endothelial cells.

Project description:Graviola (Annona muricata) is a tropical plant with many traditional ethnobotanic uses and pharmacologic applications. A metabolomic study of both aqueous and DMSO extracts from Annona muricata leaves recently allowed us to identify dozens of bioactive compounds. In the present study, we use a proteomic study to reveal new bioactivities of these leave extracts on both conditioned media and extracts of HT-1080 fibrosarcoma treated cells. Our results reveal the complete sets of deregulated proteins after treatment with aqueous and DMSO extracts from An-nona muricata leaves. Functional enrichment analysis of proteomic data suggests deregulation of cell cycle and iron metabolism, which are experimentally validated. Additional experimental data reveal that these extracts protect from ferroptosis to both HT-1080 fibrosarcoma cells and HMEC-1 endothelial cells.

2023-10-24 | PXD042354 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data